Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × NETWORK × Other hematologic neoplasm × Clear all

Phase

Status

Completed 214 Unknown 23 Active not recruiting 21 Recruiting 17 Terminated 15 Withdrawn 7 Not yet recruiting 4 Suspended 1 Enrolling by invitation 1

Sponsor Class

OTHER 24 INDUSTRY 8 NIH 7 OTHER_GOV 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06773936 2026-03-04

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

SWOG Cancer Research Network

Phase 2 Enrolling by invitation

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡